DCZ0415

Item number	Size	Delivery time	Price
TGM-T10981-1mg	1 mg	7 - 10 business days*	46.00€
TGM-T10981-5mg	5 mg	7 - 10 business days*	111.00€
TGM-T10981-1mL	1 ml	7 - 10 business days*	121.00€
TGM-T10981-10mg	10 mg	7 - 10 business days*	187.00€
TGM-T10981-25mg	25 mg	7 - 10 business days*	351.00€
TGM-T10981-50mg	50 mg	7 - 10 business days*	557.00€
TGM-T10981-100mg	100 mg	7 - 10 business days*	797.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of... more

Close menu

Product information "DCZ0415"

Description: DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-kappaB activity. Target: NF-kappaB, Others, Apoptosis. Smiles: O=C1C2C(C3C=CC2C2CC32)C(=O)N1c1ccc(Cc2ccncc2)cc1. References: Wang Y, et al. A Small Molecule Inhibitor Targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2019 Nov 15. pii: canres.3987.2018.

Supplier:	TargetMol
Supplier-Nr:	T10981

Properties

MW:	356.42 D
Formula:	C23H20N2O2

Database Information

CAS :

2242470-43-3| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "DCZ0415"

Write a review